PremiumThe FlyJazz Pharmaceuticals price target raised to $230 from $220 at Truist Chimerix Stock Hold Rating: Limited Upside Due to Acquisition Offer Price Alignment Chimerix downgraded to Hold from Buy at JonesResearch PremiumRatingsHold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals Chimerix downgraded to Neutral from Buy at H.C. Wainwright Chimerix downgraded to Neutral from Outperform at Wedbush PremiumRatingsChimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones CMRX Earnings this Week: How Will it Perform? Delta flight crashes in Toronto, Southwest cuts corporate roles: Morning Buzz 
